Published in Int J Oncol on September 21, 2012
A novel combinatorial nanotechnology-based oral chemopreventive regimen demonstrates significant suppression of pancreatic cancer neoplastic lesions. Cancer Prev Res (Phila) (2013) 1.53
Recent Advances of Curcumin and its Analogues in Breast Cancer Prevention and Treatment. RSC Adv (2015) 0.78
Ferulic acid combined with aspirin demonstrates chemopreventive potential towards pancreatic cancer when delivered using chitosan-coated solid-lipid nanoparticles. Cell Biosci (2015) 0.77
Epigenetic modulation in the treatment of atherosclerotic disease. Front Genet (2014) 0.75
Preclinical systemic toxicity evaluation of chitosan-solid lipid nanoparticle-encapsulated aspirin and curcumin in combination with free sulforaphane in BALB/c mice. Int J Nanomedicine (2016) 0.75
Nanotechnology for multimodality treatment of cancer. Oncol Lett (2016) 0.75
Cancer statistics, 2012. CA Cancer J Clin (2012) 87.38
NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature (1999) 8.42
Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev (2004) 5.31
Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur J Pharm Biopharm (2000) 4.68
A prospective study of aspirin use and the risk for colorectal adenoma. Ann Intern Med (2004) 3.46
Sulforaphane targets pancreatic tumour-initiating cells by NF-kappaB-induced antiapoptotic signalling. Gut (2008) 2.36
Anti cancer effects of curcumin: cycle of life and death. Cell Div (2008) 1.45
Calcium-activated RAF/MEK/ERK signaling pathway mediates p53-dependent apoptosis and is abrogated by alpha B-crystallin through inhibition of RAS activation. Mol Biol Cell (2005) 1.45
Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives. Int J Nanomedicine (2007) 1.41
Increased expression of cyclooxygenase-2 in human pancreatic neoplasms and potential for chemoprevention by cyclooxygenase inhibitors. Cancer (2001) 1.39
Chemoprevention strategies for pancreatic cancer. Nat Rev Gastroenterol Hepatol (2010) 1.38
Curcumin, an antioxidant and anti-tumor promoter, induces apoptosis in human leukemia cells. Biochim Biophys Acta (1996) 1.33
The effect of poloxamer 188 on nanoparticle morphology, size, cancer cell uptake, and cytotoxicity. Nanomedicine (2009) 1.32
Pancreatic cancer: pathogenesis, prevention and treatment. Toxicol Appl Pharmacol (2006) 1.24
NSAID inhibition of GI cancer growth: clinical implications and molecular mechanisms of action. Am J Gastroenterol (2002) 1.14
Curcumin induced modulation of cell cycle and apoptosis in gastric and colon cancer cells. Anticancer Res (2001) 1.13
Aspirin use and pancreatic cancer mortality in a large United States cohort. J Natl Cancer Inst (2004) 1.13
Heating decreases epithiospecifier protein activity and increases sulforaphane formation in broccoli. Phytochemistry (2004) 1.12
Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal antiinflammatory drug with D,L-alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor, in diet. Cancer Res (1990) 1.06
Studies on oral absorption of stearic acid SLN by a novel fluorometric method. Colloids Surf B Biointerfaces (2007) 1.04
Combination chemoprevention: future direction of colorectal cancer prevention. Eur J Cancer Prev (2012) 0.93
Cellular uptake and cytotoxicity of solid lipid nanospheres (SLN) incorporating doxorubicin or paclitaxel. Int J Pharm (2000) 0.88
Development and validation of a high-performance liquid chromatography method for the simultaneous determination of aspirin and folic acid from nano-particulate systems. Biomed Chromatogr (2010) 0.87
Sulforaphane: from chemoprevention to pancreatic cancer treatment? Gut (2009) 0.86
Chemopreventive effect of farnesol and lanosterol on colon carcinogenesis. Cancer Detect Prev (2002) 0.85
Chemoprevention of colon cancer in a rat carcinogenesis model using a novel nanotechnology-based combined treatment system. Cancer Prev Res (Phila) (2011) 0.85
Effect of co-solvents on the controlled release of calcitonin polypeptide from in situ biodegradable polymer implants. Drug Deliv (2005) 0.82
Chemoprevention of pancreatic cancer: ready for the clinic? Cancer Prev Res (Phila) (2010) 0.81
Chemoprevention of pancreatic cancer-one step closer. Langenbecks Arch Surg (2012) 0.80
Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure. Cell (2013) 6.47
Worldwide survey on the use of navigation in spine surgery. World Neurosurg (2012) 2.23
Guidelines for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 16: bone graft extenders and substitutes. J Neurosurg Spine (2005) 1.43
Treating type 2 diabetes mellitus with traditional chinese and Indian medicinal herbs. Evid Based Complement Alternat Med (2013) 1.34
Molecular basis of traditional Chinese medicine in cancer chemoprevention. Curr Drug Discov Technol (2010) 1.08
Guidelines for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 7: intractable low-back pain without stenosis or spondylolisthesis. J Neurosurg Spine (2005) 1.07
Guidelines for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 9: fusion in patients with stenosis and spondylolisthesis. J Neurosurg Spine (2005) 1.05
Guidelines for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 5: correlation between radiographic and functional outcome. J Neurosurg Spine (2005) 1.02
Guidelines for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 15: electrophysiological monitoring and lumbar fusion. J Neurosurg Spine (2005) 1.00
Protein kinase C delta-mediated processes in cholecystokinin-8-stimulated pancreatic acini. Pancreas (2009) 0.98
DNA mismatch repair complex MutSβ promotes GAA·TTC repeat expansion in human cells. J Biol Chem (2012) 0.97
Dynamic evaluation of cervical disc herniation using kinetic MRI. J Clin Neurosci (2010) 0.95
A novel tandem reporter quantifies RNA polymerase II termination in mammalian cells. PLoS One (2009) 0.94
Guidelines for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 4: radiographic assessment of fusion. J Neurosurg Spine (2005) 0.94
Homologous RIG-I-like helicase proteins direct RNAi-mediated antiviral immunity in C. elegans by distinct mechanisms. Proc Natl Acad Sci U S A (2013) 0.91
LC-MS/MS quantification of a neuropeptide fragment kisspeptin-10 (NSC 741805) and characterization of its decomposition product and pharmacokinetics in rats. J Chromatogr B Analyt Technol Biomed Life Sci (2013) 0.90
Guidelines for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 10: fusion following decompression in patients with stenosis without spondylolisthesis. J Neurosurg Spine (2005) 0.89
Developing phytoestrogens for breast cancer prevention. Anticancer Agents Med Chem (2012) 0.89
Nanoparticulate delivery of novel drug combination regimens for the chemoprevention of colon cancer. Int J Oncol (2010) 0.88
A thoracic and lumbar spine injury severity classification based on neurologic function grade, spinal canal deformity, and spinal biomechanical stability. Spine J (2006) 0.87
Preparation of liposomal vancomycin and intracellular killing of meticillin-resistant Staphylococcus aureus (MRSA). Int J Antimicrob Agents (2010) 0.87
Development and validation of a high-performance liquid chromatography method for the simultaneous determination of aspirin and folic acid from nano-particulate systems. Biomed Chromatogr (2010) 0.87
Development and stability studies of novel liposomal vancomycin formulations. ISRN Pharm (2012) 0.87
Guidelines for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 2: assessment of functional outcome. J Neurosurg Spine (2005) 0.86
Guidelines for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 8: lumbar fusion for disc herniation and radiculopathy. J Neurosurg Spine (2005) 0.86
Guidelines for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 17: bone growth stimulators and lumbar fusion. J Neurosurg Spine (2005) 0.85
Increased prevalence of celiac disease in patients with unexplained infertility in the United States. J Reprod Med (2011) 0.85
Chemoprevention of colon cancer in a rat carcinogenesis model using a novel nanotechnology-based combined treatment system. Cancer Prev Res (Phila) (2011) 0.85
Guidelines for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 11: interbody techniques for lumbar fusion. J Neurosurg Spine (2005) 0.84
Spontaneous chronic epidural hematoma of the lumbar spine mimicking an extradural spine tumour. Eur Spine J (2012) 0.83
The molecular mechanism of action of aspirin, curcumin and sulforaphane combinations in the chemoprevention of pancreatic cancer. Oncol Rep (2013) 0.83
Effect of culture medium volume and embryo density on early mouse embryonic development: tracking the development of the individual embryo. J Assist Reprod Genet (2012) 0.83
Guidelines for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 6: magnetic resonance imaging and discography for patient selection for lumbar fusion. J Neurosurg Spine (2005) 0.82
Shifts in cell-type expression accompany a diminishing role of spinal p38-mapkinase activation over time during prolonged postoperative pain. Anesthesiology (2011) 0.80
Traditional Chinese medicinal formula Si-Wu-Tang prevents oxidative damage by activating Nrf2-mediated detoxifying/antioxidant genes. Cell Biosci (2014) 0.80
The pharmacokinetics of enteric-coated mycophenolate sodium and its gastrointestinal side effects in de novo renal transplant recipients of Hispanic ethnicity. Ther Drug Monit (2011) 0.80
Antiviral RNA silencing initiated in the absence of RDE-4, a double-stranded RNA binding protein, in Caenorhabditis elegans. J Virol (2013) 0.80
Influence of botulinum toxin on rabbit jaw muscle activity and anatomy. Muscle Nerve (2012) 0.79
Pharmacogenomics approach reveals MRP1 (ABCC1)-mediated resistance to geldanamycins. Pharm Res (2008) 0.79
Longevity depends on a balance between proinflammatory and anti-inflammatory factors: use of TCMS and natural products. Curr Drug Discov Technol (2010) 0.78
Conjugation with cationic cell-penetrating peptide increases pulmonary absorption of insulin. Mol Pharm (2009) 0.78
PEGylated liposome encapsulation increases the lung tissue concentration of vancomycin. Antimicrob Agents Chemother (2011) 0.78
Genetic variations and gene expression of transporters in drug disposition and response. Expert Opin Drug Metab Toxicol (2008) 0.78
Guidelines for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 1: introduction and methodology. J Neurosurg Spine (2005) 0.77
Guidelines for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 12: pedicle screw fixation as an adjunct to posterolateral fusion for low-back pain. J Neurosurg Spine (2005) 0.76
In situ monitoring of soil dissolution dynamics: a rapid and simple method for determining worst-case soils for cleaning validation. PDA J Pharm Sci Technol (2004) 0.76
Prospective, open-label investigation of the pharmacokinetics of daptomycin during cardiopulmonary bypass surgery. Antimicrob Agents Chemother (2011) 0.75
Origins of eponymous orthopaedic equipment. Clin Orthop Relat Res (2010) 0.75
Effect of lumbar angular motion on central canal diameter: positional MRI study in 491 cases. Chin Med J (Engl) (2010) 0.75
Image analysis algorithms for immunohistochemical assessment of cell death. Methods Mol Biol (2015) 0.75
Guidelines for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 14: brace therapy as an adjunct to or substitute for lumbar fusion. J Neurosurg Spine (2005) 0.75
Bilateral megaureters may masquerade as hydrosalpinges on ultrasound. Reprod Biomed Online (2009) 0.75
Triptolide and celastrol loaded silk fibroin nanoparticles show synergistic effect against human pancreatic cancer cells. Nanoscale (2017) 0.75
Guidelines for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 3: assessment of economic outcome. J Neurosurg Spine (2005) 0.75
Renal artery stenosis: to intervene, or not to intervene, "that is the question". Semin Dial (2013) 0.75
Phytochemical analysis of medicinal plants with kidney protective activities. Chin J Integr Med (2011) 0.75
Guidelines for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 13: injection therapies, low-back pain, and lumbar fusion. J Neurosurg Spine (2005) 0.75
Antitumor activity of NPB001-05, an orally active inhibitor of Bcr-Abl tyrosine kinase. Front Biosci (Elite Ed) (2011) 0.75